{"id":"W4243460686","doi":"10.1186/s13058-019-1196-y","title":"NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Trastuzumab; Medicine; Neratinib; Oncology; Internal medicine; Breast cancer; Cyclophosphamide; Chemotherapy; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001693094,0.0009325015,0.001694172,0.00024955,0.0002309998,0.0005898454,0.000496473,0.0007018366,0.002333078],"category_scores_gemma":[0.000877607,0.0003966614,0.0009356933,0.0002264411,0.0007661081,0.0005205778,0.0002506361,0.001806202,0.0003963511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007494986,"about_ca_system_score_gemma":0.001203681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009352093,"about_ca_topic_score_gemma":0.003033349,"domain_scores_codex":[0.9995323,0.0002806547,0.00002280761,0.00005539315,0.00005504753,0.00005386243],"domain_scores_gemma":[0.9995364,0.0000966981,0.00008854378,0.00004029942,0.00003877014,0.0001994283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9248214,0.01716193,0.002674982,0.0004466668,0.001102811,0.0000553683,0.00005855809,0.00126429,0.0152699,0.0001596029,0.001173785,0.03581081],"study_design_scores_gemma":[0.7142338,0.2710871,0.007930962,0.00004231057,0.0006305834,0.0001472071,0.00003750847,0.001698852,0.002728049,0.00019369,0.001241441,0.00002848893],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960669,0.001340242,0.0002586425,0.0002293588,0.0001374847,0.0009257943,0.0003605327,0.0000354356,0.0006455894],"genre_scores_gemma":[0.9889972,0.001771989,0.002002022,0.000784456,0.0001886308,0.002411421,0.001681341,0.0000232075,0.002139707],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002333078,"threshold_uncertainty_score":0.008954048,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03781533341049981,"score_gpt":0.4208535751548812,"score_spread":0.3830382417443814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}